title: PPARgamma2 Pro12Ala polymorphism in relation to free fatty acids concentration and composition in lean healthy Czech individuals with and without family history of diabetes type 2.
abstract: Free fatty acids (FFAs) are natural ligands of the PPARgamma2 receptor. FFA plasma concentration and composition may represent one of the factors accounting for high heterogeneity of conclusions concerning the effect of the Pro12Ala on BMI, insulin sensitivity or diabetes type 2 (DM2) susceptibility. Our objective was to investigate the relation and possible interactions between the Pro12Ala polymorphism and FFA status, metabolic markers, and body composition in 324 lean nondiabetic subjects (M/F: 99/225; age 32+/-11 years; BMI 23.9+/-4.0 kg/m(2)) with and without family history of DM2. Family history of DM2 was associated with lower % PUFA and slightly higher % MUFA. The presence of Pro12Ala polymorphism was not associated with fasting plasma FFA concentration or composition, anthropometric or metabolic markers of glucose and lipid metabolism in tested population. However, the interaction of carriership status with FFA levels influenced the basal glucose levels, insulin sensitivity and disposition indices, triglycerides, HDL-cholesterol and leptin levels, especially in women. The metabolic effects of 12Ala carriership were influenced by FFA levels - the beneficial role of 12Ala was seen only in the presence of low concentration of plasma FFA. Surprisingly, a high PUFA/SFA ratio was associated with lower insulin sensitivity, the protective effect of 12Ala allele was apparent in subjects with family history of DM2. On the basis of our findings and published data we recommend the genotyping of diabetic patients for Pro12Ala polymorphism of the PPARgamma2 gene before treatment with thiazolidinediones and education of subjects regarding diet and physical activity, which modulate metabolic outcomes.
authors.affiliation: Institute of Endocrinology, Prague, Czech Republic. bbendlova@endo.cz
authors.forename: B
authors.initials: B
authors.lastname: Bendlová
authors.forename: D
authors.initials: D
authors.lastname: Vejražková
authors.forename: J
authors.initials: J
authors.lastname: Včelák
authors.forename: P
authors.initials: P
authors.lastname: Lukášová
authors.forename: D
authors.initials: D
authors.lastname: Burkoňová
authors.forename: M
authors.initials: M
authors.lastname: Kunešová
authors.forename: J
authors.initials: J
authors.lastname: Vrbíková
authors.forename: K
authors.initials: K
authors.lastname: Dvoráková
authors.forename: K
authors.initials: K
authors.lastname: Vondra
authors.forename: M
authors.initials: M
authors.lastname: Vanková
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D001823:Body Composition / Q000235:genetics; D001835:Body Weight / Q000235:genetics*; D018153:Czech Republic; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics*; D004734:Energy Metabolism / Q000235:genetics; D005192:Family Health; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D050417:Insulin-Secreting Cells / Q000502:physiology; D008297:Male; D047495:PPAR gamma / Q000235:genetics*; D011110:Polymorphism, Genetic; D011972:Receptor, Insulin
chemical_list: D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D047495:PPAR gamma; D011972:Receptor, Insulin